This announcement is a separate document:
新诺威：国投证券关于石药创新制药股份有限公司发行股份购买资产并募集配套资金暨关联交易之2023年度持续督导意见暨持续督导总结报告
New Novus: SDIC Securities's 2023 Continued Supervision Opinions and Continued Supervision Summary Report on the Issuance of Shares by Shiyao Innovative Pharmaceutical Co., Ltd. to purchase assets and raise supporting capital and related transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.